| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.034 | 0.5 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.5 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.5 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |